| 000 | 01790 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250518042858.0 | ||
| 264 | 0 | _c20200504 | |
| 008 | 202005s 0 0 eng d | ||
| 022 | _a1502-7732 | ||
| 024 | 7 |
_a10.1080/03009742.2019.1614213 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDavid, C | |
| 245 | 0 | 0 |
_aSoluble CD163 is a biomarker for accelerated atherosclerosis in systemic lupus erythematosus patients at apparent low risk for cardiovascular disease. _h[electronic resource] |
| 260 |
_bScandinavian journal of rheumatology _cJan 2020 |
||
| 300 |
_a33-37 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntigens, CD _xblood |
| 650 | 0 | 4 |
_aAntigens, Differentiation, Myelomonocytic _xblood |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xblood |
| 650 | 0 | 4 |
_aCarotid Arteries _xdiagnostic imaging |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPlaque, Atherosclerotic _xblood |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xblood |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aUltrasonography |
| 650 | 0 | 4 | _aCD163 Antigen |
| 700 | 1 | _aDivard, G | |
| 700 | 1 | _aAbbas, R | |
| 700 | 1 | _aEscoubet, B | |
| 700 | 1 | _aChezel, J | |
| 700 | 1 | _aChauveheid, M P | |
| 700 | 1 | _aRouzaud, D | |
| 700 | 1 | _aBoutten, A | |
| 700 | 1 | _aPapo, T | |
| 700 | 1 | _aDehoux, M | |
| 700 | 1 | _aSacre, K | |
| 773 | 0 |
_tScandinavian journal of rheumatology _gvol. 49 _gno. 1 _gp. 33-37 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1080/03009742.2019.1614213 _zAvailable from publisher's website |
| 999 |
_c29761986 _d29761986 |
||